Market Analysis - Antibiotics 2020
The global antibiotics market was valued at USD 42,653.89 million in 2018, and is estimated to be valued at USD 56,369.92 million in 2024, witnessing a CAGR of 4.7%.The Antibacterial Drugs market is expected to cross US$ 38 Billion by 2024 growing at a CAGR of 1% during the given forecast period. Rising pervasiveness of irresistible illnesses particularly in creating locales, for example, Asia Pacific and MEA is foreseen to contribute towards showcase development.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players include Allergen plc, AstraZeneca plc, Bayer AG, Bristol-Myers Squibb Company, Eli Lilly & Co., Forest Laboratories, Inc., GlaxoSmithKline plc, Merck & Co., Inc. Novartis AG, Pfizer, Inc., and Sanofi.
The antibiotics market generated sales of US$42 billion in 2009 globally, representing 46% of sales of anti-infective agents (which also include antiviral drugs and vaccines) and 5% of the global pharmaceutical market. However, the antibiotics market is maturing; it showed an average annual growth of 4% over the past 5 years, compared with a growth of 16.7% and of 16.4% for antiviral drugs and vaccines, respectively.
Over 15.0% of the passing’s, in kids underneath the age of five, are assessed to be because of pneumonia and as indicated by the insights given by the WHO around 9.2 million passing’s were recorded in 2015. Like tuberculosis, the most elevated commonness of the sickness is recognized to be in the South Asian and Sub-Saharan locales. At present, the required anti-infection treatment is accessible just to 33% of the tainted populace, subsequently expanding the illness trouble.
The major driving factors of Antibacterial Drugs Market are as follows:
- There is a very high prevalence of infectious diseases.
- The research and development activities have increased.
- Product differentiation through various methods.
- Increased government support.
The restraining factors of Antibacterial drugs Market is as follows:
Importance and Scope
Antibiotic resistance is rising to dangerously high levels in all parts of the world. New resistance mechanisms are emerging and spreading globally, threatening our ability to treat common infectious diseases. A growing list of infections such as pneumonia, tuberculosis, blood poisoning, gonorrhoea, and foodborne diseases are becoming harder, and sometimes impossible, to treat as antibiotics become less effective.
Where antibiotics can be bought for human or animal use without a prescription, the emergence and spread of resistance is made worse. Similarly, in countries without standard treatment guidelines, antibiotics are often over-prescribed by health workers and veterinarians and over-used by the public. Without urgent action, we are heading for a post-antibiotic era, in which common infections and minor injuries can once again kill.
- Gilead Sciences
- Abbott Laboratories
- Merck & Co
- Eli Lilly
- Astellas Pharma
- Teva Pharmaceutical Industries
- Boehringer Ingelheim
- 3-D Matrix
- Fosun Pharma
Related Associations and Societies
- World Health Organization
- U.S. Food and Drug Administration (FDA)
- Natural Resources Defense Council (NRDC)
- Infectious Diseases Society of America
- World Health Assembly
- Center for a Livable Future (CLF)
- The Humane Society of the United States (HSUS)
- Alliance for the Prudent Use of Antibiotics
- Civil Society Organisations
- British Society for Antimicrobial Chemotherapy
- Pediatric Infectious Diseases Society
- Royal Society of Medicine
- European Society of Clinical Microbiology and Infectious Diseases
- CAESAR (Central Asian & Eastern European Surveillance of Antimicrobial Resistance)
- WAAAR - World Alliance Against Antibiotic Resistance
- ReAct – Action on Antibiotic Resistance
- American Medical Association
Antibiotics 2020 invites all the participants from all over the world to attend “7th World Congress and Exhibition on Antibiotics and Antibiotic Resistance” to be held on March 16-17, 2020 | London, UK which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.
We organize a series of 1000+ Global Events inclusive of 1000+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Why to attend?
Antibiotics 2020 is a platform to discuss and learn about the latest advancements in the field of Antibiotics and Antibiotic Resistance as the world’s consideration turned regarding the urgency of new antibiotics as the antimicrobial resistance is growing day by day. Many developed nations and International health organizations are trying to focus of the current situation and making new policies to prevent the adverse effects of Antibiotic resistance.
The 2-day conference gathers Researchers, academia, labs, Drug Manufacturers, government agencies, health professionals, hospitals, young investigators, Pharma and labs and presents their opinions through key notes, and case study presentations. This conference lays a platform for all the researchers working in the field of Antibiotics to know the latest developments and the current situation of the Antibiotic resistance problem.
- Healthcare Students, Scientists, and professors
- Bacteriology Researchers
- Faculty of bacteriology and infectious diseases
- Medical Colleges
- Healthcare Associations and Societies
- Business Entrepreneurs
For Universities, Associations & Societies:
- Association Partnering
- Collaboration proposals
- Academic Partnering
- Group Participation
For Students and Research Scholars
For Business Delegates
For Product Manufacturers
- Exhibitor and Vendor Booths
- Sponsorships opportunities
- Product launch
- Workshop organizing
- Scientific Partnering
- Marketing and Networking with clients